标题
Targeting PI3K/AKT/mTOR network for treatment of leukemia
作者
关键词
PI3K, Akt, mTOR, Rapamycin, Leukemia, MicroRNAs, Kinase inhibitors
出版物
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 72, Issue 12, Pages 2337-2347
出版商
Springer Nature
发表日期
2015-02-24
DOI
10.1007/s00018-015-1867-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment
- (2015) Alberto M. Martelli et al. Oncotarget
- Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels
- (2015) Daniela Bressanin et al. Oncotarget
- Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation
- (2015) Carolina Simioni et al. Oncotarget
- Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110 , for relapsed/refractory chronic lymphocytic leukemia
- (2014) J. R. Brown et al. BLOOD
- Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis
- (2014) J Bertacchini et al. LEUKEMIA
- Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches
- (2014) Fatemeh Salari et al. MEDICAL ONCOLOGY
- PTEN Regulates BCRP/ABCG2 and the Side Population through the PI3K/Akt Pathway in Chronic Myeloid Leukemia
- (2014) Fang-Fang Huang et al. PLoS One
- The Antiproliferative Activity of Kinase Inhibitors in Chronic Myeloid Leukemia Cells Is Mediated by FOXO Transcription Factors
- (2014) Francesca Pellicano et al. STEM CELLS
- New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia
- (2014) Saeid Shahrabi et al. TUMOR BIOLOGY
- Effect of CAL-101, a PI3Kδ inhibitor, on ribosomal rna synthesis and cell proliferation in acute myeloid leukemia cells
- (2014) L X T Nguyen et al. Blood Cancer Journal
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
- (2013) Carl Sandén et al. BMC CANCER
- Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis
- (2013) Wei Ding et al. BRITISH JOURNAL OF HAEMATOLOGY
- Proliferation of PTEN-deficient haematopoietic tumour cells is not affected by isoform-selective inhibition of p110β PI3-kinase and requires blockade of all class 1 PI3K activity
- (2013) Chloe Stengel et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with nilotinib against BCR-ABL-positive leukemia cells involves the ABL kinase domain mutation
- (2013) Seiichi Okabe et al. CANCER BIOLOGY & THERAPY
- The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells
- (2013) Célia Rosilio et al. CANCER LETTERS
- RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
- (2013) Ralph Fritsch et al. CELL
- The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia
- (2013) J-N Gong et al. CELL DEATH AND DIFFERENTIATION
- Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity
- (2013) Siddhartha Sen et al. EXPERIMENTAL HEMATOLOGY
- Disruption of the PI3K/AKT/mTOR signaling cascade and induction of apoptosis in HL-60 cells by an essential oil from Monarda citriodora
- (2013) Anup Singh Pathania et al. FOOD AND CHEMICAL TOXICOLOGY
- The roles of miR-146a in the differentiation of Jurkat T-lymphoblasts
- (2013) Najmaldin Saki et al. Hematology
- Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics
- (2013) Naif AlQurashi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Notch1 Receptor Regulates AKT Protein Activation Loop (Thr308) Dephosphorylation through Modulation of the PP2A Phosphatase in Phosphatase and Tensin Homolog (PTEN)-null T-cell Acute Lymphoblastic Leukemia Cells
- (2013) Eric C. Hales et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential
- (2013) L M Neri et al. LEUKEMIA
- Genomic Landscapes and Clonality of De Novo AML
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Tanshinone IIA Induces Autophagic Cell Death via Activation of AMPK and ERK and Inhibition of mTOR and p70 S6K in KBM-5 Leukemia Cells
- (2013) Sun-Mi Yun et al. PHYTOTHERAPY RESEARCH
- AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin
- (2013) David B. Rosen et al. PLoS One
- Selective Akt Inhibitors Synergize with Tyrosine Kinase Inhibitors and Effectively Override Stroma-Associated Cytoprotection of Mutant FLT3-Positive AML Cells
- (2013) Ellen Weisberg et al. PLoS One
- Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts
- (2013) Gilles M. Leclerc et al. PLoS One
- mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin
- (2013) S. A. Kang et al. SCIENCE
- PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor
- (2013) K Airiau et al. Cell Death & Disease
- “Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia’’
- (2013) P Oppezzo et al. Blood Cancer Journal
- Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway
- (2012) Y. Li et al. BLOOD
- Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment
- (2012) Z. Zeng et al. BLOOD
- PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response
- (2012) C Shepherd et al. LEUKEMIA
- Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia
- (2012) M R Janes et al. LEUKEMIA
- The study of resistant mechanisms and reversal in an imatinib resistant Ph+ acute lymphoblastic leukemia cell line
- (2012) Hongyun Xing et al. LEUKEMIA RESEARCH
- Antileukemic effects of AMPK activators on BCR-ABL-expressing cells
- (2011) E. Vakana et al. BLOOD
- The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia
- (2011) Teresa Palomero et al. CELL CYCLE
- The physiology and pathophysiology of rapamycin resistance
- (2011) Philip A. Gruppuso et al. CELL CYCLE
- Micro RNAs as a new therapeutic target towards leukaemia signalling
- (2011) Megan Y. Murray et al. CELLULAR SIGNALLING
- Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors
- (2011) J. K. Altman et al. CLINICAL CANCER RESEARCH
- Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
- (2011) Carlo Gambacorti-Passerini et al. JNCI-Journal of the National Cancer Institute
- Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts
- (2011) G Fuka et al. LEUKEMIA
- The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia
- (2011) L Willems et al. LEUKEMIA
- Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis
- (2011) Chong Zhang et al. LEUKEMIA RESEARCH
- MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R
- (2011) Cheng You Jia et al. PLoS One
- Philadelphia Chromosome Symposium: commemoration of the 50th anniversary of the discovery of the Ph chromosome
- (2011) H. Sharat Chandra et al. Cancer Genetics
- AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species
- (2010) M. M. Juntilla et al. BLOOD
- The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation
- (2010) A. S. Green et al. BLOOD
- AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells
- (2010) A. F. Santidrian et al. BLOOD
- Phosphatidylinositol 3-kinase- inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
- (2010) S. E. M. Herman et al. BLOOD
- Activity of the Novel Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 against T-Cell Acute Lymphoblastic Leukemia
- (2010) F. Chiarini et al. CANCER RESEARCH
- Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
- (2010) N. Chapuis et al. CLINICAL CANCER RESEARCH
- Targeting the BCR-ABL Signaling Pathway in Therapy-Resistant Philadelphia Chromosome-Positive Leukemia
- (2010) T. O'Hare et al. CLINICAL CANCER RESEARCH
- Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept
- (2010) P. Valent CURRENT CANCER DRUG TARGETS
- Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
- (2010) Haitao Bai et al. FEBS LETTERS
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Modulation of Akt and ERK1/2 Pathways by Resveratrol in Chronic Myelogenous Leukemia (CML) Cells Results in the Downregulation of Hsp70
- (2010) Soumyajit Banerjee Mustafi et al. PLoS One
- High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia
- (2009) A. Gutierrez et al. BLOOD
- Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
- (2009) Margaret A. Knowles et al. CANCER AND METASTASIS REVIEWS
- Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition
- (2009) J. Zhuang et al. HAEMATOLOGICA
- Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody
- (2009) N. Chapuis et al. HAEMATOLOGICA
- Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways
- (2009) W-L Zhao LEUKEMIA
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
- (2008) R. Garzon et al. BLOOD
- Additive effects of PI3-kinase and MAPK activities on NB4 cell granulocyte differentiation: potential role of phosphatidylinositol 3-kinase γ
- (2008) Sebastian Scholl et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Acute lymphoblastic leukaemia
- (2008) Ching-Hon Pui et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now